| Original language | English |
|---|---|
| Publication date | 14. Sep 2016 |
| Publication status | Published - 14. Sep 2016 |
| Event | 32nd ECTRIMS: Congress of the European Committee for Treatment and Research in Multiple Sclerosis - ExCeL London, London, United Kingdom Duration: 14. Sep 2016 → 17. Sep 2016 |
Conference
| Conference | 32nd ECTRIMS |
|---|---|
| Location | ExCeL London |
| Country | United Kingdom |
| City | London |
| Period | 14/09/2016 → 17/09/2016 |
Cite this
}
Multiple sclerosis disease rebound after treatment switch from fingolimod to alemtuzumab. / Willis, M; Pearson, O; Illés, Zsolt; Nielsen, C; Mathiesen, Tobias Sejbæk ; Duddy, Martin; Petheram, K; van Munster, C; Killestein, J; Uitdehaag, B; Malmestrom, C; Tallantyre, E; Robertson, N.
2016. Poster session presented at 32nd ECTRIMS, London, United Kingdom.Research output: Contribution to conference without publisher/journal › Poster › Research
TY - CONF
T1 - Multiple sclerosis disease rebound after treatment switch from fingolimod to alemtuzumab
AU - Willis, M
AU - Pearson, O
AU - Illés, Zsolt
AU - Nielsen, C
AU - Mathiesen, Tobias Sejbæk
AU - Duddy, Martin
AU - Petheram, K
AU - van Munster, C
AU - Killestein, J
AU - Uitdehaag, B
AU - Malmestrom, C
AU - Tallantyre, E
AU - Robertson, N
PY - 2016/9/14
Y1 - 2016/9/14
M3 - Poster
ER -